Tag Archives: Mark Harrington

With TB research threatened, doctors, patients, advocates and filmmakers spell out risks

By on .

At a recent conference of medical researchers, National Institute of Allergy and Infectious Diseases Director Anthony Fauci spelled out what lawmakers appear to be missing in their budget balancing efforts. “They don’t realize,” Fauci said, “that hitting biomedical research now is going to have an impact, three, four years from now.” So efforts to let […]

FDA panel finds new type of TB drug effective, raising hopes for treatment of drug-resistant strains

By on .

Dr. Dalene von Delft had a choice between dying  or going deaf, and that was a choice only if the arduous treatment she was undergoing for drug-resistant tuberculosis worked. The South African pediatrician had contracted a resistant strain of the disease caring for patients, and the only potentially effective treatment was showing one of its […]

Mark Harrington: US Cannot Pull Back on HIV Treatment Scale Up

By on .

In this video, Mark Harrington, executive director of the Treatment Action Group, discusses the resources needed to “catch up” with the HIV epidemic and the urgency of expanding treatment to save lives. Harrington explains this pressing need in the context of a shift in US global health policy and the global economic recession. Harrington spoke […]

Public and Private Sector Partners Help to Jump Start Development of New TB Drug Combinations

By on .

This post is by Global Center Director Christine Lubinski. The excitement in the room was palatable today as FDA Commissioner Margaret Hamburg joined representatives from the Global Alliance for TB Drug Development, the Bill & Melinda Gates Foundation, the Treatment Action Campaign, and representatives from the pharmaceutical industry to announce a new collaboration to accelerate […]